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Introduction
INVOS measures cerebral oxygen saturation. A 100
patient audit examining the efficacy of INVOS showed a
reduction in mortality and post-operative length of stay
(LOS) against national statistics [1]. Our aim was to ana-
lyse the cost effectiveness of INVOS in mixed and coron-
ary bypass (CABG) only cardiac surgery by comparing the
INVOS group to a control group.
Methods
A cost analysis of the INVOS group was done by compar-
ing against 100 control patients who underwent surgery
immediately prior to the INVOS audit. Hospital finance
data was used to calculate costs. The areas for comparison
were cost of: INVOS equipment; ICU and non-ICU post-
operative LOS; stroke rehabilitation. Previous INVOS stu-
dies have focused on CABG only patients [2,3]. In order to
compare outcomes with those found in these studies we
selected the CABG only patients out of the two groups.
This data was then analysed to give a final saving for
CABG only patients.
Results
Despite the equipment cost, all other outcomes had a
reduced cost in the INVOS group. Overall there was a
saving of £102,000 per 100 patients undergoing cardiac
surgery. There was improvement in all outcomes in
both INVOS (n=65) and the control group (n=66) once
the criteria of CABG only had been applied. LOS was
reduced in both groups, and neither group contained an
incident of stroke. This resulted in an even greater
saving of £114,000 per 100 CABG only patients. Both
comparisons, mixed and CABG only, showed the biggest
cost saving to be due to a reduction in post-operative
LOS both in ICU and on the wards. This correlates with
the findings of previous studies [2,3].
Conclusions
This cost analysis shows a significant saving when using
INVOS in the management of both mixed and CABG
only cardiac surgery. The CABG only patients showed
the greatest saving of £114,000 per 100 patients. Pre-
vious literature only considered CABG patients and did
not undertake any cost analysis. However, further analy-
sis with mixed cardiac surgery and a randomised trial is
required.
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